Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a safe, effective way to significantly reduce symptoms in premenopausal women with uterine leiomyomas, according to the results of a multicenter clinical trial.
Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a safe, effective way to significantly reduce symptoms in premenopausal women with uterine leiomyomas, according to the results of a multicenter clinical trial.
Researchers found that of 109 women undergoing MRgFUS, 71% experienced at least a 10-point reduction in symptom severity score on the Uterine Fibroid Quality-of-Life Instrument at 6 months after the procedure and 51% of 82 women did so at 12 months. Symptoms were reduced on average 39% and 36% at 6 and 12 months, respectively.
No deaths, life-threatening events, or thromboembolic events occurred during the 6 months postsurgery. There were no unintended second procedures or separate interventional treatments provided. And no patients were discharged with a urinary catheter. Six percent of patients developed fever, and 5% had skin burns where hair removal was incomplete. Mean time to return to work after the procedure was 1 day.
Peer support programs: A powerful solution to alleviate physician burnout
December 6th 2023Discover how the implementation of peer support initiatives, such as the successful Peer Outreach Support Team, is revolutionizing healthcare culture, reducing burnout rates, and fostering positive changes among physicians.
Read More